drugset / Trial / NCT04309643
Drug-drug Interaction Study of CTP-543 and Oral Contraceptives in Healthy Female Subjects
SequentialOpen-labelOther
Summary
This is a Phase 1, fixed sequence, multiple dose, open-label study of the effect of CTP-543 on oral contraceptive pharmacokinetics in healthy female subjects.
Timeline
- Start
- 2020-06-09
- Primary completion
- 2020-06-25
- Completion
- 2020-07-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CTP-543 | Unknown | — | Oral |
| Subject | Levonorgestrel | Small molecule | 0.15 mg | Oral |
| Subject | ethinyl estradiol | Small molecule | 0.03 mg | Oral |
Indications
No indication recorded.